| scholarly article | Q13442814 |
| P2093 | author name string | Mei Lu | |
| Mary Beth Perri | |||
| Marcus J Zervos | |||
| Carol L Moore | |||
| Susan Donabedian | |||
| Nadia Z Haque | |||
| Paola Osaki-Kiyan | |||
| Faiqa Cheema | |||
| P2860 | cites work | Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia | Q28145964 |
| Invasive methicillin-resistant Staphylococcus aureus infections in the United States | Q29616087 | ||
| Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study | Q29616607 | ||
| Outcome assessment of minimizing vancomycin monitoring and dosing adjustments | Q33860155 | ||
| Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus | Q34073407 | ||
| Emergence of resistance among USA300 methicillin-resistant Staphylococcus aureus isolates causing invasive disease in the United States | Q34108596 | ||
| Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia | Q34783668 | ||
| Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients | Q34991274 | ||
| Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors | Q35793612 | ||
| Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia | Q35879117 | ||
| Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity | Q36538707 | ||
| Molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates in urban Detroit | Q36747581 | ||
| Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database | Q37059039 | ||
| Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists | Q37537565 | ||
| Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology | Q37553599 | ||
| Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus | Q40542104 | ||
| Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus | Q41873909 | ||
| A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides | Q42912582 | ||
| Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia | Q44453815 | ||
| Obvious lack of association between dynamics of epidemic methicillin-resistant Staphylococcus aureus in central Europe and agr specificity groups | Q44678030 | ||
| Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy | Q44959085 | ||
| High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity | Q45302930 | ||
| Comparative evaluation of epidemiology and outcomes of methicillin-resistant Staphylococcus aureus (MRSA) USA300 infections causing community- and healthcare-associated infections. | Q46036617 | ||
| Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections | Q46431265 | ||
| Adequacy of a vancomycin dosing regimen in patients receiving high-flux hemodialysis | Q46720261 | ||
| Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia | Q46826194 | ||
| Predicting prognosis after stroke: a placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial | Q73147749 | ||
| Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up | Q74460196 | ||
| A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia | Q80783502 | ||
| Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets | Q83770914 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Staphylococcus aureus | Q188121 |
| methicillin-resistant Staphylococcus aureus | Q595158 | ||
| P304 | page(s) | 4581-4588 | |
| P577 | publication date | 2011-08-08 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Prediction of failure in vancomycin-treated methicillin-resistant Staphylococcus aureus bloodstream infection: a clinically useful risk stratification tool | |
| P478 | volume | 55 |
| Q35607603 | Acid sphingomyelinase inhibition protects mice from lung edema and lethal Staphylococcus aureus sepsis |
| Q35942872 | Analysis of pathogen and host factors related to clinical outcomes in patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus |
| Q64115391 | Antibiotic use practice and predictors of hospital outcome among patients with systemic bacterial infection: Identifying targets for antibiotic and health care resource stewardship |
| Q40072209 | Clinical and microbiological factors associated with early patient mortality from methicillin-resistant Staphylococcus aureus bacteremia. |
| Q34441035 | Clinical management of Staphylococcus aureus bacteremia: a review |
| Q30836832 | Comparative effectiveness research of chronic hepatitis B and C cohort study (CHeCS): improving data collection and cohort identification |
| Q26749132 | Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections |
| Q50047637 | Disruption of staphylococcal aggregation protects against lethal lung injury. |
| Q41681261 | Engineered liposomes sequester bacterial exotoxins and protect from severe invasive infections in mice |
| Q33703659 | Human cathelicidin LL-37 resistance and increased daptomycin MIC in methicillin-resistant Staphylococcus aureus strain USA600 (ST45) are associated with increased mortality in a hospital setting |
| Q37544314 | Multicenter prospective observational study of the comparative efficacy and safety of vancomycin versus teicoplanin in patients with health care-associated methicillin-resistant Staphylococcus aureus bacteremia |
| Q40483780 | Retrospective analysis of vancomycin treatment outcomes in Chinese paediatric patients with suspected Gram-positive infection |
| Q47586716 | Staphylococcus aureus Alpha-Toxin Disrupts Endothelial-Cell Tight Junctions via Acid Sphingomyelinase and Ceramide |
| Q91742696 | The Continuing Threat of Methicillin-Resistant Staphylococcus aureus |
| Q39458281 | Validity of an automated algorithm using diagnosis and procedure codes to identify decompensated cirrhosis using electronic health records |
Search more.